Doomsday Chorus Targeting Kennedy Gets Louder
In a show of protest against budget and staffing cuts at the U.S. Centers for Disease Control and Prevention (CDC), former employees of the agency, scientists, and community activists organized a “die-in” demonstration outside the CDC’s Roybal Road campus in Atlanta, Georgia. On May 2, 2025, the Trump administration proposed a budget to Congress for […]
Study of First Next Generation mRNA Bird Flu Shots in Cattle Published
Researchers at the University of Pennsylvania have published a study based on their experimental use of a next generation mRNA bird flu vaccine tested on cattle.1 Last year, the U.S. Department of Agriculture (USDA) agreed to give the novel mRNA biological developed by the University of Pennsylvania to cattle in an attempt to protect dairy […]
New Jersey Bill Requires Automatic Enrollment in State Electronic Vaccine Tracking Registry
Lawmakers in New Jersey have approved legislation that would require enrollment in the state’s electronic vaccine tracking registry, unless citizens actively opt out in writing. The bill for an “opt-out” vaccine tracking system, rather than operating an “opt-in” system, comes in response to decreased vaccination rates in recent years and health officials maintain it will […]
CDC Vaccine Advisory Panel Purged
On June 9, 2025, U.S. Secretary of Health and Human Services Robert F. Kennedy, Jr. fired all 17 members of the U.S. Centers for Disease Control and Prevention’s (CDC) committee that makes national vaccine policy—the Advisory Committee on Immunization Practices (ACIP). “A clean sweep is necessary to reestablish public confidence in vaccine science,” Secretary Kennedy […]
FDA Approves MenQuadfi Meningococcal Vaccine for Six-Week-Old Infants
The U.S. Food and Drug Administration (FDA) has licensed Sanofi’ SA’s four-valent MenQuadfi meningococcal vaccine for use in infants aged six weeks to 23 months old to prevent invasive meningococcal disease. Previously approved for children aged two and older, MenQuadfi is now the first meningococcal vaccine included on the U.S. Centers for Disease Control and […]
FDA Licenses Moderna’s mNEXSPIKE COVID Shot for Individuals at High Risk for Severe COVID Disease
On May 30, 2025, the U.S. Food and Drug Administration (FDA) licensed mNEXSPIKE (mRNA-1283), a newly developed mRNA COVID-19 biologic for individuals who have previously received any COVID shots and are either 65 years of age or older, or between 12 and 64 years old with at least one underlying medical condition that increases their […]